Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Nanoink appoints Ben Pothast chief financial officer

Abstract:
NanoInk, Inc. announced today the appointment of Ben Pothast, as its chief financial officer.

Nanoink appoints Ben Pothast chief financial officer

SKOKIE, IL | Posted on February 19th, 2008

"We are thrilled that Ben has joined the NanoInk team," said Jim Hussey, CEO of NanoInk. "Ben brings more than 20 years of diverse financial experience to NanoInk. We believe his excellent track record at some of the world's leading pharmaceutical companies will help drive our future growth."

Mr. Pothast joins NanoInk from Cambridge Major Laboratories, Inc., a privately held service-based chemistry outsourcing partner to the world's leading pharmaceutical and biotechnology companies, where he served as chief financial officer. Mr. Pothast was the first CFO in the company's history and a key member of the management team.

Previously, Mr. Pothast was vice president of planning and analysis at Ovation Pharmaceuticals, Inc., a leading biopharmaceutical company. At Ovation, Mr. Pothast was responsible for all treasury and portfolio management functions. He was a key member of the acquisition team focused on due diligence and debt and equity financing.

Prior to his work at Ovation Pharmaceuticals, Mr. Pothast served as chief financial officer of Akorn, Inc., a publicly traded specialty pharmaceutical company that develops, manufactures and markets ophthalmic and injectable products.

Mr. Pothast began his career at Ernst & Young in Chicago and is a certified public accountant. He holds a B.A. in Accounting and Business Administration from Augustana College and a Masters of Management from the Kellogg Graduate School of Business at Northwestern University.

####

About NanoInk, Inc.
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the lifescience and semiconductor industries. With DPN, a patented and proprietary nanofabrication technology that allows for unmatched flexibility and accuracy, and also its high-resolution Nanoencryption technology, NanoInk is able to offer its pharmaceutical customers innovative solutions to fight counterfeiting and illegal diversion of blockbuster pharmaceutical products. Other key applications include nanoscale additive repair, and nanoscale rapid prototyping. Located in the new Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 100 issued or pending patents and patent applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, the University of Illinois at Urbana-Champaign, and the Georgia Institute of Technology.

For more information, please click here

Contacts:
David Gutierrez
Dresner Corporate Services
NanoInk
312-780-7204


Joshua Taustein
Dresner Corporate Services
NanoInk
312-780-7219

Copyright © NanoInk, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Nanoparticles could allow for faster, better medicine: Exposure of nanoparticles in the body allows for more effective delivery November 20th, 2017

ICN2 researchers compute unprecedented values for spin lifetime anisotropy in graphene November 17th, 2017

Math gets real in strong, lightweight structures: Rice University researchers use 3-D printers to turn century-old theory into complex schwarzites November 16th, 2017

The stacked color sensor: True colors meet minimization November 16th, 2017

Nanomedicine

Nanoparticles could allow for faster, better medicine: Exposure of nanoparticles in the body allows for more effective delivery November 20th, 2017

Nanobiotix presented new clinical and pre-clinical data confirming NBTXR3ís significant potential role in Immuno-Oncology at SITC Annual Meeting November 14th, 2017

Arrowhead to Present at 29th Annual Piper Jaffray Healthcare Conference November 14th, 2017

A new way to mix oil and water: Condensation-based method developed at MIT could create stable nanoscale emulsions November 8th, 2017

Announcements

Nanoparticles could allow for faster, better medicine: Exposure of nanoparticles in the body allows for more effective delivery November 20th, 2017

ICN2 researchers compute unprecedented values for spin lifetime anisotropy in graphene November 17th, 2017

Math gets real in strong, lightweight structures: Rice University researchers use 3-D printers to turn century-old theory into complex schwarzites November 16th, 2017

The stacked color sensor: True colors meet minimization November 16th, 2017

Appointments/Promotions/New hires/Resignations/Deaths

Nanometrics Board of Directors Names Pierre-Yves Lesaicherre President and CEO November 14th, 2017

180 Degree Capital Corp. Appoints Investment Banking Veteran Parker Weil to Its Board of Directors August 2nd, 2017

Nanometrics Announces Retirement Plans of CEO Timothy Stultz: Dr. Stultz to Continue as Director May 25th, 2017

180 Degree Capital Corp. Announces the Start of Kevin Rendino as Chairman and Chief Executive Officer and Completion of its Transition to a Registered Closed-End Fund March 31st, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project